Key takeaway
What This Development Means
Chromium trioxide is suspected of causing cancer but the Commission decides that the benefits of these users far outweigh the risks. Learn Foresight.
The European Commission has recently issued decisions regarding the authorisation for marketing and use of substances listed under Annex XIV of the REACH Regulation (EC) No 1907/2006. These decisions, integral to the Registration, Evaluation, Authorisation, and Restriction of Chemicals framework, have far-reaching implications for industries and stakeholders involved.
Key Decision: Chromium Trioxide Authorisations
Decision Reference C(2023) 7338 – Dated 15th November 2023
Substance: Chromium Trioxide (EC No. 215-607-8, CAS No. 1333-82-0)Authorisation Holder: Dornbracht AG & Co. KG, GermanyAuthorisation Number: REACH/23/22/0Authorised Use: Decorative functional chrome plating for sanitary applicationsReview Period Expiry: 31st December 2028Decision Rationale: The socio-economic benefits were deemed to outweigh the risks to health and the environment, with no viable alternatives available.
Decision Reference C(2023)7339 – Dated 15th November 2023
- Substance: Chromium Trioxide - Authorisation Holders and Uses: - Ideal Standard Vidima AD, Bulgaria (REACH/23/21/0): Electroplating for durable, high-quality surfaces in sanitary applications. - Ideal Standard Produktions-GmbH, Germany (REACH/23/21/1) and Ideal Standard Vidima AD, Bulgaria (REACH/23/21/2): Etching of plastics as a pre-treatment in electroplating for sanitary applications. - Review Period Expiry: 31st December 2028 - Decision Rationale: Similar to the above, the socio-economic benefits were found to surpass the associated health and environmental risks, with no suitable alternatives identified.
Implications And Actions For Stakeholders
These decisions underscore the importance of balancing socio-economic factors with health and environmental risks in chemical use.
Stakeholders must note:
Compliance Obligations: Ensure adherence to the specific conditions of the authorisation, particularly concerning safety measures and environmental protections.Review and Adaptation: Regularly review processes to align with evolving REACH regulations and explore potential alternative substances or technologies.Documentation and Reporting: Maintain thorough records and reports as required under REACH, demonstrating compliance and monitoring of authorised substance use.
Related Articles
EU REACH Restrictions Face Scrutiny Over CMRs In Childcare Products And Lead Ammunition
The EU REACH Committee will debate major restrictions on CMRs in childcare products and lead ammunition, while NGOs criticise delays in wider chemical regulation. The proposals could tighten compliance requirements across European supply chains.
EU Updates REACH Annex XVII To Tighten CMR Restrictions And Clarify Derogations
The proposed REACH Annex XVII update expands CMR restrictions, introduces new substances and clarifies derogations for specific uses. By aligning with CLP classifications and tightening mixture rules, the regulation increases compliance complexity and underscores the need for proactive chemical risk management across EU supply chains.
CoRAP Update 2026–2028 Flags 27 Substances For REACH Evaluation
The CoRAP update 2026–2028 identifies 27 substances for evaluation under REACH, focusing on persistent, toxic and endocrine-disrupting chemicals. The plan underscores growing regulatory scrutiny and requires proactive data management, risk assessment and supply chain adjustments across the chemicals industry.
